Cardio Diagnostics Holdings, Inc. Quarterly Debt-to-equity in % from Q3 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cardio Diagnostics Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q3 2022 to Q2 2024.
  • Cardio Diagnostics Holdings, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 65.1 %, a 13.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 65.1 +7.9 +13.8% Jun 30, 2024
Q1 2024 92.2 +62.8 +214% Mar 31, 2024
Q4 2023 122 +110 +896% Dec 31, 2023
Q3 2023 113 +108 +2119% Sep 30, 2023
Q2 2023 57.2 Jun 30, 2023
Q1 2023 29.4 Mar 31, 2023
Q4 2022 12.3 Dec 31, 2022
Q3 2022 5.09 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.